Donald B. Axworthy - Concepedia

Author

Donald B. Axworthy

University of Washington

Also Known As

D Axworthy, D B Axworthy, D. Axworthy, D. B. Axworthy, Donald Axworthy, Donald B Axworthy, Donald B. Axworthy

Publications

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center National Cancer Institute Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa Immunovaccine (Canada)

About

Donald B. Axworthy is an author at University of Washington specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Natural Sciences	5	5	175
3	Biochemistry	4	4	122
4	Engineering	3	3	295
5	Health Sciences	2	2	109

Donald B. Axworthy

Publications

Citations

H-Index

Page 1

	Year	Citations
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity Donald B. Axworthy, J. M. Reno, Mark D. Hylarides, Proceedings of the National Academy of Sciences Colon Cancer XenograftsImmunology600-800 MicrociPeak UptakeTumor Biology	2000	230
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. SJ Knox, Michael L. Goris, Margaret A. Tempero, PubMed ImmunologyGastroenterologyPathologyPhase Ii StudyPharmacotherapy	2000	212
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. Hazel B. Breitz, Paul L. Weiden, Paul L. Beaumier, PubMed EngineeringEvaluated.the Optimal SchemaImmunologyImmunotherapyTheranostics	2000	151
A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy. Jody Schultz, Yukang Lin, James Sanderson, PubMed EngineeringB9e9 Monoclonal AntibodyImmunologyGlycobiologyPathology	2000	127
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. Michael R. Lewis, Mu Wang, Donald B. Axworthy, PubMed	2003	110
Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Kurt Hoffmann, Anthony J. Streeter, Donald B. Axworthy, Molecular Pharmacology	1985	106
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts Meili Zhang, Zhuo Zhang, Kayhan Garmestani, Proceedings of the National Academy of Sciences	2003	105
Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213 Meili Zhang, Zhengsheng Yao, Kayhan Garmestani, Blood	2002	103
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas John M. Pagel, Nathan Hedin, Krishnan Subbiah, Blood	2003	101
A Genetically Engineered Anti-CD45 Single-Chain Antibody-Streptavidin Fusion Protein for Pretargeted Radioimmunotherapy of Hematologic Malignancies Yukang Lin, John M. Pagel, Donald B. Axworthy, Cancer Research Cell TherapyImmunologyBc8 Fusion ProteinImmunotherapyHematological Malignancy	2006	64

Page 1